Alteration in kidney glucose and amino acids are implicated in renal pathology in MRL/lpr mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 10, 2007, Pages 1143-1149

  Alexander, Jessy J ^a   Zwingmann, Claudia ^b   Jacob, Alexander ^a   Quigg, Richard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

13C NMR spectroscopy; Autoimmune; Glucose; Kidney; MRL lpr

Indexed keywords

AMINO ACID; GLUCOSE; GLUTATHIONE; PROTEIN KINASE C DELTA; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; WATER CONTENT;

AMINO ACIDS; ANIMALS; C-REACTIVE PROTEIN; CITRIC ACID CYCLE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOLYSIS; KIDNEY; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED MRL LPR; RECEPTORS, COMPLEMENT; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 36549027458     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.07.002     Document Type: Article

References (41)

1. Adachi M., Watanabe-Fukunaga R., and Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1756
2. Alexander J.J., Lim A., He C., MacDonald R.L., Holers V.M., and Quigg R.J. Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury. Immunopharmacology 42 (1999) 245
3. Bao L., Haas M., Kraus D.M., Hack B.K., Rakstang J.K., Holers V.M., and Quigg R.J. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J. Am. Soc. Nephrol. 14 (2003) 670
4. Bao L., Zhou J., Holers V.M., and Quigg R.J. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J. Am. Soc. Nephrol. 14 (2003) 2516
5. Cameron J.S. Systemic lupus erythematosus. In: Neilson E.G., and Couser W.G. (Eds). Immunologic Renal Diseases (1997), Lippincott-Raven, Philadelphia, PA 1055-1098
6. Cameron J.S. Lupus nephritis. J. Am. Soc. Nephrol. 10 (1999) 413
7. Cheng D.W., Jiang Y., Shalev A., Kowluru R., Crook E.D., and Singh L.P. An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells. Arch. Physiol. Biochem. 112 (2006) 189
8. Davis Jr. J.C., Manzi S., Yarboro C., Rairie J., Mcinnes I., Averthelyi D., Sinicropi D., Hale V.G., Balow J., Austin H., Boumpas D.T., and Klippel J.H. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus 8 (1999) 68
9. DeFronzo R.A., Cooke C.R., Goldberg M., Cox M., Myers A.R., and Agus Z.S. Impaired renal tubular potassium secretion in systemic lupus erythematosus. Ann. Intern. Med. 86 (1977) 268
10. Guder W.G., and Ross B.D. Enzyme distribution along the nephron. Kidney Int. 26 (1984) 101
11. Hahn B.H. Systemic lupus erythematosus. J. Fla. Med. Assoc. 82 (1995) 332
12. Hahn B.H. Lessons in lupus: the mighty mouse. Lupus 10 (2001) 589
13. Hahn B.H. Systemic lupus erythematosus and accelerated atherosclerosis. N. Engl. J. Med. 349 (2003) 2379
14. Hahn B.H. Animal models of systemic lupus erythematosus. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' Lupus Erythematosus (2001), Williams and Wilkins, Baltimore, MD 339-388
15. Heilig C.W., Kreisberg J.I., Freytag S., Murakami T., Ebina Y., Guo L., Heilig K., Loberg R., Qu X., Jin Y., Henry D., and Brosius III F.C. Antisense GLUT1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. Am. J. Physiol., Renal Fluid Electrolyte Physiol. 280 (2001) F657-F666
16. Heitmann R.N., and Bergman E.N. Glutamate interconversions and glucogenicity in the sheep. Am. J. Physiol. 241 (1981) E465-E472
17. Kiley J., and Zager P. Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus. Am. J. Kidney Dis. 4 (1984) 39
18. Kim Y.-U., Kinoshita T., Molina H., Hourcade D., Seya T., Wagner L.M., and Holers V.M. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181 (1995) 151
19. Kozeny G.A., Barr W., Bansal V.K., Vertuno L.L., Fresco R., Robinson J., and Hano J.E. Occurrence of renal tubular dysfunction in lupus nephritis. Arch. Intern. Med. 147 (1987) 891
20. Kreisberg J.I., and Kreisberg S.H. High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int. Suppl 51 (1995) S3
21. Li B., Sallee C., Dehoff M., Foley S., Molina H., and Holers V.M. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151 (1993) 4295
22. Nicholson-Weller A., and Halperin J.A. Membrane signaling by complement C5b9, the membrane attack complex. Immunol. Res. 12 (1993) 244
23. Paolisso G., Valentini G., Giugliano D., Marrazzo G., Tirri R., Gallo M., Tirri G., Varricchio M., and 'Onofrio F.D. Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism 40 (1991) 902
24. Pio R., Martinez A., Unsworth E.J., Kowalak J.A., Bengoechea J.A., Zipfel P.F., Elsasser T.H., and Cuttitta F. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276 (2001) 12292
25. Powell L.A., Nally S.M., McMaster D., Catherwood M.A., and Trimble E.R. Restoration of glutathione levels in vascular smooth muscle cells exposed to high glucose conditions. Free Radic. Biol. Med. 31 (2001) 1149
26. Quigg R.J., He C., Lim A., Berthiaume D., Alexander J.J., Kraus D., and Holers V.M. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J. Exp. Med. 188 (1998) 1321
27. Schiller B., Cunningham P.N., Alexander J.J., Bao L., Holers V.M., and Quigg R.J. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure. J. Am. Soc. Nephrol. 12 (2001) 71
28. Schnaper H.W., Hayashida T., and Poncelet A.C. It's a Smad world: regulation of TGF-beta signaling in the kidney. J. Am. Soc. Nephrol. 13 (2002) 1126
29. Schnaper H.W., Hayashida T., Hubchak S.C., and Poncelet A.C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol., Renal Fluid Electrolyte Physiol. 284 (2003) F243-F252
30. Schnaper H.W., Hayashida T., and Poncelet A.C. It's a Smad world: regulation of TGF-beta signaling in the kidney. J. Am. Soc. Nephrol. 13 (2002) 1126
31. Sharma K., Jin Y., Guo J., and Ziyadeh F.N. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45 (1996) 522
32. Stumvoll M., Meyer C., Kreider M., Perriello G., and Gerich J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism 47 (1998) 1227
33. Stumvoll M., Meyer C., Mitrakou A., Nadkarni V., and Gerich J.E. Renal glucose production and utilization: new aspects in humans. Diabetologia 40 (1997) 749
34. Stumvoll M., Perriello G., Meyer C., and Gerich J. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int. 55 (1999) 778
35. Walport M.J. Advances in immunology: complement (second of two parts). N. Engl. J. Med. 344 (2001) 1140
36. Walport M.J. Advances in immunology: complement (first of two parts). N. Engl. J. Med. 344 (2001) 1058
37. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314
38. Wong W., and Fearon D.T. p65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J. Immunol. 134 (1985) 4048
39. Ziyadeh F.N. The extracellular matrix in diabetic nephropathy. Am. J. Kidney Dis. 22 (1993) 736
40. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De La Cruz M.C., Hong S.W., Isono M., Chen S., McGowan T.A., and Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice [see comments]. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8015
41. 13CNMR. NMR Biomed. 16 (2003) 370